stock.name

Mirati Therapeutics Inc

MRTX

Market Cap$0
Close$

Compare Mirati Therapeutics

P/E RatioDividendsReturn on EquityPrice-to-SalesDebt-to-Equity
Mirati Therapeutics IncMirati Therapeutics Inc00%-77%--
marketMarket Avg59.61.27%31%6.41
HealthcareHealthcare Avg62.31.27%15%7.30.9
$66.66

Current Fair Value

13.6% upside

Undervalued by 13.6% based on the discounted cash flow analysis.

Share Statistics

Market cap$0.00
Enterprise Value$-976,434,000.00
Dividend Yield$0.0 (0.0%)
Earnings per Share$-12.15
Beta0.0
Outstanding Shares70,147,706
Avg 30 Day Volume0

Return

Return on Equity-
Return on Assets-
Return on Invested Capital-

Valuation & Multiples

P/E Ratio0.0
PEG-0.0
Price to Sales-
Price to Book Ratio4.52
Enterprise Value to Revenue-25.57
Enterprise Value to EBIT1.28
Enterprise Value to Net Income1
Total Debt to Enterprise0
Debt to Equity0

Revenue Sources

No data

ESG Score

No data

About Mirati Therapeutics Inc

CEO: Charles Baum